Tekla Life Sciences Investors vs Tencent Holdings Ltd ADR
A head-to-head of Tekla Life Sciences Investors (HQL) and Tencent Holdings Ltd ADR (TCEHY) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | HQL | TCEHY |
|---|---|---|
| Market Cap | $553.12M | $547.50B |
| P/E (TTM) | 3.07 | 16.92 |
| Forward P/E | 0.00 | 13.76 |
| P/S | 285.35 | 0.73 |
| P/B | 1.02 | 3.28 |
| EV/EBITDA | 0.00 | 10.52 |
| Dividend Yield | 10.14% | 1.12% |
| Profit Margin | 505.41% | 29.90% |
| Gross Margin | 100.00% | 56.21% |
| Operating Margin | 99.08% | 32.56% |
| Revenue Growth (YoY) | +463.30% | +11.16% |
| FCF Yield | — | — |
| Debt / Equity | — | 34.04 |
| Current Ratio | 1.74 | 1.44 |
Share:
Compare Tekla Life Sciences Investors with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.